Isto Technologies

About:

ISTO Technologies is an orthobiologics firm developing biologic products to regenerate and restore function to damaged cartilage and bone.

Website: http://www.istotech.com

Top Investors: National Institutes of Health, EQT Life Sciences, NIST, Ascension Ventures, Alafi Capital

Description:

ISTO Technologies, Inc., an orthobiologics company, develops biologic products to regenerate and restore function to damaged cartilage and bone. It offers InQu, a resorbable bone graft extender and substitute; NuQu, a cell-based injectable therapy for disc regeneration; and DeNovo ET, an engineered cartilage implant for the repair and regeneration of knee cartilage. The company provides its products through distributors. ISTO Technologies, Inc. was founded in 1997 and is based in St. Louis, Missouri.

Total Funding Amount:

$33.9M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

St Louis, Missouri, United States

Founded Date:

1997-01-01

Contact Email:

customerservice(AT)istotech.com

Founders:

Joseph Feder

Number of Employees:

51-100

Last Funding Date:

2015-07-29

IPO Status:

Private

Industries:

© 2025 bioDAO.ai